VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 13, 2021

Total Value ($000): $824,402 (100.0% shares, 0.0% debt)

Holdings (29)

— INSTIL BIO INC 16.1%

Value ($000) $132,633 Shares 6,865,076 Est. Cost $25.08 Unrealized —

ACRS ACLARIS THERAPEUTICS INC 9.7%

Value ($000) $80,143 Shares 4,563,962 Est. Cost $13.57 Unrealized +67.4%

— VISTAGEN THERAPEUTICS INC 6.1%

Value ($000) $50,549 Shares 16,047,286 Est. Cost $2.02 Unrealized —

— GRAPHITE BIO INC 6.0%

Value ($000) $49,556 Shares 1,612,617 Est. Cost $30.73 Unrealized —

— MARINUS PHARMACEUTICALS INC 5.7%

Value ($000) $47,394 Shares 2,641,809 Est. Cost $12.27 Unrealized —

RLMD RELMADA THERAPEUTICS INC 5.4%

Value ($000) $44,421 Shares 1,387,720 Est. Cost $37.46 Unrealized -7.3%

OLMA OLEMA PHARMACEUTICALS INC 5.2%

Value ($000) $42,983 Shares 1,536,193 Est. Cost $46.89 Unrealized -39.3%

CLDX CELLDEX THERAPEUTICS INC 5.0%

Value ($000) $41,486 Shares 1,240,610 Est. Cost $15.71 Unrealized +74.7%

ALT ALTIMMUNE INC 4.2%

Value ($000) $34,475 Shares 3,500,000 Est. Cost $5.49 Unrealized +148.9%

— KINNATE BIOPHARMA INC 4.2%

Value ($000) $34,292 Shares 1,473,014 Est. Cost $39.78 Unrealized —

GHRS GH RESEARCH PLC 3.4%

Value ($000) $27,724 Shares 1,275,831 Est. Cost $20.43 Unrealized 0.0%

CGEM CULLINAN ONCOLOGY INC 3.0%

Value ($000) $25,136 Shares 976,145 Est. Cost $40.60 Unrealized -24.2%

CNTA CENTESSA PHARMACEUTICALS PLC 3.0%

Value ($000) $25,037 Shares 1,127,272 Est. Cost $22.21 Unrealized —

— PROVENTION BIO INC 3.0%

Value ($000) $24,470 Shares 2,902,744 Est. Cost $8.43 Unrealized —

— TRILLIUM THERAPEUTICS INC 2.4%

Value ($000) $19,416 Shares 2,001,686 Est. Cost $4.63 Unrealized —

— ESSA PHARMA INC 2.2%

Value ($000) $17,878 Shares 625,754 Est. Cost $29.05 Unrealized —

CVRX CVRX INC 2.2%

Value ($000) $17,734 Shares 633,370 Est. Cost $28.00 Unrealized 0.0%

PHVS PHARVARIS NV 2.0%

Value ($000) $16,821 Shares 902,882 Est. Cost $31.46 Unrealized -27.9%

— ATHIRA PHARMA INC 1.8%

Value ($000) $15,206 Shares 1,485,005 Est. Cost $20.05 Unrealized —

— RAPT THERAPEUTICS INC 1.5%

Value ($000) $12,430 Shares 391,000 Est. Cost $31.79 Unrealized —

KURA KURA ONCOLOGY INC 1.5%

Value ($000) $11,989 Shares 575,000 Est. Cost $14.42 Unrealized +72.1%

KROS KEROS THERAPEUTICS INC 1.4%

Value ($000) $11,565 Shares 272,306 Est. Cost $30.81 Unrealized +75.8%

COGT COGENT BIOSCIENCES INC 1.1%

Value ($000) $8,830 Shares 1,088,817 Est. Cost $10.99 Unrealized -23.1%

— ALIGOS THERAPEUTICS INC 1.0%

Value ($000) $8,325 Shares 408,377 Est. Cost $27.65 Unrealized —

— AKOYA BIOSCIENCES INC 0.9%

Value ($000) $7,736 Shares 400,000 Est. Cost $19.34 Unrealized —

— HARPOON THERAPEUTICS INC 0.9%

Value ($000) $7,102 Shares 512,005 Est. Cost $13.87 Unrealized —

— CATABASIS PHARMACEUTICALS INC 0.8%

Value ($000) $6,824 Shares 3,234,000 Est. Cost $2.11 Unrealized —

— ADICET BIO INC 0.2%

Value ($000) $1,890 Shares 183,702 Est. Cost $13.08 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 0.0%

Value ($000) $357 Shares 19,495 Est. Cost $15.07 Unrealized +13.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	INSTIL BIO INC	6,865,076	$132,633	16.1%	$25.08	—	COM	45783C101
ACRS	ACLARIS THERAPEUTICS INC	4,563,962	$80,143	9.7%	$13.57	+67.4%	COM	00461U105
—	VISTAGEN THERAPEUTICS INC	16,047,286	$50,549	6.1%	$2.02	—	COM	92840H202
—	GRAPHITE BIO INC	1,612,617	$49,556	6.0%	$30.73	—	COM	38870X104
—	MARINUS PHARMACEUTICALS INC	2,641,809	$47,394	5.7%	$12.27	—	COM	56854Q200
RLMD	RELMADA THERAPEUTICS INC	1,387,720	$44,421	5.4%	$37.46	-7.3%	COM	75955J402
OLMA	OLEMA PHARMACEUTICALS INC	1,536,193	$42,983	5.2%	$46.89	-39.3%	COM	68062P106
CLDX	CELLDEX THERAPEUTICS INC	1,240,610	$41,486	5.0%	$15.71	+74.7%	COM	15117B202
ALT	ALTIMMUNE INC	3,500,000	$34,475	4.2%	$5.49	+148.9%	COM	02155H200
—	KINNATE BIOPHARMA INC	1,473,014	$34,292	4.2%	$39.78	—	COM	49705R105
GHRS	GH RESEARCH PLC	1,275,831	$27,724	3.4%	$20.43	0.0%	ORD SH	G3855L106
CGEM	CULLINAN ONCOLOGY INC	976,145	$25,136	3.0%	$40.60	-24.2%	COM	230031106
CNTA	CENTESSA PHARMACEUTICALS PLC	1,127,272	$25,037	3.0%	$22.21	—	SPONS ADS	152309100
—	PROVENTION BIO INC	2,902,744	$24,470	3.0%	$8.43	—	COM	74374N102
—	TRILLIUM THERAPEUTICS INC	2,001,686	$19,416	2.4%	$4.63	—	COM	89620X506
—	ESSA PHARMA INC	625,754	$17,878	2.2%	$29.05	—	COM	29668H708
CVRX	CVRX INC	633,370	$17,734	2.2%	$28.00	0.0%	COM	126638105
PHVS	PHARVARIS NV	902,882	$16,821	2.0%	$31.46	-27.9%	COM	N69605108
—	ATHIRA PHARMA INC	1,485,005	$15,206	1.8%	$20.05	—	COM	04746L104
—	RAPT THERAPEUTICS INC	391,000	$12,430	1.5%	$31.79	—	COM	75382E109
KURA	KURA ONCOLOGY INC	575,000	$11,989	1.5%	$14.42	+72.1%	COM	50127T109
KROS	KEROS THERAPEUTICS INC	272,306	$11,565	1.4%	$30.81	+75.8%	COM	492327101
COGT	COGENT BIOSCIENCES INC	1,088,817	$8,830	1.1%	$10.99	-23.1%	COM	19240Q201
—	ALIGOS THERAPEUTICS INC	408,377	$8,325	1.0%	$27.65	—	COM	01626L105
—	AKOYA BIOSCIENCES INC	400,000	$7,736	0.9%	$19.34	—	COM	00974H104
—	HARPOON THERAPEUTICS INC	512,005	$7,102	0.9%	$13.87	—	COM	41358P106
—	CATABASIS PHARMACEUTICALS INC	3,234,000	$6,824	0.8%	$2.11	—	COM	14875P206
—	ADICET BIO INC	183,702	$1,890	0.2%	$13.08	—	COM	007002108
VRDN	VIRIDIAN THERAPEUTICS INC	19,495	$357	0.0%	$15.07	+13.5%	COM	92790C104